HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Diabetic ketoacidosis associated with tacrolimus in solid organ transplant recipients.

Abstract
Diabetic ketoacidosis in patients receiving tacrolimus in the post-transplant setting is rare. We describe two such cases in solid-organ transplant recipients. The first patient, a 17-year-old male, presented with severe diabetic ketoacidosis and was managed with intravenous fluids and insulin infusion. He was a known case of Laurence-Moon-Bardet-Biedl syndrome and had received a renal transplant 2 years ago and was receiving tacrolimus since then. Although diabetic ketoacidosis resolved in 24 hours, large doses of subcutaneous insulin (upto 130 units per day) were needed to keep serum glucose within the normal range. Substitution of tacrolimus with cyclosporine obviated the need for insulin or oral hypoglycaemics. The second patient, a 55-year-old woman, presented with a history of polyuria for 3 days. She had received a hepatic transplant 2 years ago and tacrolimus was being used since then. Mild diabetic ketoacidosis was managed with fluid resuscitation and subcutaneous insulin. Her insulin requirement after an uneventful recovery has been 54 - 70 units per day. Clinicians should be cognizant of the possibility of hyperglycaemic crisis presenting as sudden onset of diabetic ketocidosis in patients receiving tacrolimus. Use of an alternative calcineurin inhibitor may provide a safer solution to minimize future morbidity in such patients.
AuthorsMuhammad Qamar Masood, Madiha Rabbani, Wasim Jafri, Manal Habib, Taimur Saleem
JournalJPMA. The Journal of the Pakistan Medical Association (J Pak Med Assoc) Vol. 61 Issue 3 Pg. 288-90 (Mar 2011) ISSN: 0030-9982 [Print] Pakistan
PMID21465949 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Hypoglycemic Agents
  • Immunosuppressive Agents
  • Insulin
  • Tacrolimus
Topics
  • Adolescent
  • Diabetic Ketoacidosis (chemically induced, drug therapy)
  • Female
  • Humans
  • Hyperglycemia (chemically induced, drug therapy)
  • Hypoglycemic Agents (administration & dosage)
  • Immunosuppressive Agents (adverse effects)
  • Injections, Subcutaneous
  • Insulin (administration & dosage)
  • Kidney Transplantation (immunology)
  • Liver Transplantation (immunology)
  • Male
  • Middle Aged
  • Postoperative Complications
  • Tacrolimus (adverse effects)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: